1. A randomized, intraindividual, non‐inferiority, Phase III study comparing daylight photodynamic therapy with BF‐200 ALA gel and MAL cream for the treatment of actinic keratosis. (14th August 2018) Authors: Dirschka, T.; Ekanayake‐Bohlig, S.; Dominicus, R.; Aschoff, R.; Herrera‐Ceballos, E.; Botella‐Estrada, R.; Hunfeld, A.; Kremser, M.; Schmitz, B.; Lübbert, H.; Puig, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 2(2019) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Factor VIII Bypassing Activity (FEIBA) assays: standardization and development of the 1st NIBSC Working Standard for FEIBA – results from a collaborative study. (23rd November 2012) Authors: Raut, S.; Daniels, S.; Gärtner, P.; Hunfeld, A.; Leitner, M.; Hockley, J.; Heath, A. Journal: Haemophilia Issue: Volume 19:Number 2(2013:Mar.) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thromboembolic events associated with immunoglobulin treatment. Issue 1 (9th February 2013) Authors: Funk, M. B.; Gross, N.; Gross, S.; Hunfeld, A.; Lohmann, A.; Guenay, S.; Hanschmann, K. M.; Keller‐Stanislawski, B. Journal: Vox sanguinis Issue: Volume 105:Issue 1(2013) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗